E-LIB Suche - Ergebnisse für: Imai, Yasuharu

1

Magnetic resonance imaging‐based risk factors of hepatocell..:

Ichikawa, Shintaro ; Motosugi, Utaroh ; Sawai, Yoshiyuki...
Hepatology Research. 54 (2023) 1 - p. 43-53 , 2023

2

Letter: serum growth differentiation factor 15 predicts hep..:

Myojin, Yuta ; Hikita, Hayato ; Tahata, Yuki...
Alimentary Pharmacology & Therapeutics. 55 (2022) 8 - p. 1061-1062 , 2022

Link: https://doi.org/10.1111/..

3

Prediction Model for Intrahepatic Distant Recurrence After ..:

Takigawa, Atsuo ; Sakamori, Ryotaro ; Tahata, Yuki...
Digestive Diseases and Sciences. 67 (2022) 12 - p. 5704-5711 , 2022

Link: https://doi.org/10.1007/..

4

Multiomics identifies the link between intratumor steatosis..:

Murai, Hiroki ; Kodama, Takahiro ; Maesaka, Kazuki...
Hepatology. , 2022

Link: https://doi.org/10.1002/..

5

Improved Liver Function After Sustained Virologic Response ..:

Tahata, Yuki ; Sakamori, Ryotaro ; Yamada, Ryoko...
Digestive Diseases and Sciences. 68 (2022) 5 - p. 2115-2122 , 2022

Link: https://doi.org/10.1007/..

6

Comparison of atezolizumab plus bevacizumab and lenvatinib ..:

Maesaka, Kazuki ; Sakamori, Ryotaro ; Yamada, Ryoko...
Hepatology Research. 52 (2022) 7 - p. 630-640 , 2022

Link: https://doi.org/10.1111/..

7

The FIB-4 Index Predicts the Development of Liver-Related E..:

Kamada, Yoshihiro ; Munekage, Kensuke ; Nakahara, Takashi...
Nutrients. 15 (2022) 1 - p. 66 , 2022

Link: https://doi.org/10.3390/..

8

Interleukin-6 Is a Circulating Prognostic Biomarker for Hep..:

Myojin, Yuta ; Kodama, Takahiro ; Sakamori, Ryotaro...
Cancers. 14 (2022) 4 - p. 883 , 2022

Link: https://doi.org/10.3390/..

9

Changes in Liver and Splenic Stiffness after Direct-Acting ..:

Sugio, Ryo ; Sawai, Yoshiyuki ; Fukuda, Kazuto...
GastroHep. 2022 (2022) - p. 1-8 , 2022

Link: https://doi.org/10.1155/..

10

Serum Mac‐2 binding protein level predicts the development ..:

Kamada, Yoshihiro ; Nakahara, Takashi ; Munekage, Kensuke...
Hepatology Communications. 6 (2022) 7 - p. 1527-1536 , 2022

Link: https://doi.org/10.1002/..

11

Serum growth differentiation factor 15 predicts hepatocellu..:

Myojin, Yuta ; Hikita, Hayato ; Tahata, Yuki...
Alimentary Pharmacology & Therapeutics. 55 (2021) 4 - p. 422-433 , 2021

Link: https://doi.org/10.1111/..

12

Management of Hepatocellular Carcinoma in Japan: JSH Consen..:

Kudo, Masatoshi ; Kawamura, Yusuke ; Hasegawa, Kiyoshi...
Liver Cancer. 10 (2021) 3 - p. 181-223 , 2021

Link: https://doi.org/10.1159/..

13

Letter: evaluation and proposed reclassification of HCC pre..:

Tahata, Yuki ; Sakamori, Ryotaro ; Yamada, Ryoko...
Alimentary Pharmacology & Therapeutics. 55 (2021) 2 - p. 258-259 , 2021

Link: https://doi.org/10.1111/..

14

Hyperprogressive disease in patients with unresectable hepa..:

Maesaka, Kazuki ; Sakamori, Ryotaro ; Yamada, Ryoko...
Hepatology Research. 52 (2021) 3 - p. 298-307 , 2021

Link: https://doi.org/10.1111/..

15

Prediction model for hepatocellular carcinoma occurrence in..:

Tahata, Yuki ; Sakamori, Ryotaro ; Yamada, Ryoko...
Alimentary Pharmacology & Therapeutics. 54 (2021) 10 - p. 1340-1349 , 2021

Link: https://doi.org/10.1111/..